AstraZeneca PLC shed £15 billion of market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill. The company UK:AZN said its lead product ...

and persistent effects in terms of weight loss (up to -8.3% from baseline) were also observed on the 57th day of follow-up, 4 weeks after the administration of the last pill. Based on a ...

(Bloomberg) -- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies ...

We use cookies to give users the best content and online experience. By clicking “Accept All Cookies”, you agree to allow us to use all cookies. Visit our Privacy ...

Virat Kohli and Rohit Sharma came under fire Monday as India chewed over a 3-0 Test series home defeat to New Zealand, with critics calling the team ageing and low on confidence. The cricket ...

Data reported earlier Monday from Viking Therapeutics (NASDAQ:VKTX) on its weight loss medicine VK2735 indicates ... in both as an injectable and in pill form, is most closely related to Lilly's ...

"Losing 3-0 at home is a tough pill to swallow and it calls for introspection," former skipper Sachin Tendulkar wrote on social media. "Was it lack of preparation, was it poor shot selection or ...

Viking Therapeutics shares surge as VK2735 shows significant weight loss in early-stage study, with plans for a phase 2 study by end of 2024. Market cautious ahead of election and Fed decision.

But what’s ridiculous is how the 2-7 Giants keep finding new ways to melt down, which is a sign ... allow none and still lose in regulation. Then when the offense actually has a decent day ...